Skip to main content
OpenTrials
Completed

NCT Number: NCT07106840

Autism Traits in Adolescents With Social Anxiety Disorder: Associations With Parental Broader Autism Phenotype

This observational study aims to examine autism-related traits in adolescents diagnosed with social anxiety disorder (SAD) and to evaluate their associations with broader autism phenotype (BAP) features in their parents. A total of 109 adolescents aged 11-17 and their parents were included. Standardized scales were used to assess social anxiety severity and autism traits in adolescents, and BAP characteristics in parents.

Completed

Looking for future studies?

Notify Me

Key information

Age range

11 year–17 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Ankara Bilkent City Hospital

Ankara, 06810, Turkey (Türkiye)

About this study

Autism spectrum traits and social anxiety share clinical and cognitive features, particularly in the domains of social communication and interaction. These overlaps suggest that autistic traits may be present in adolescents diagnosed with social anxiety disorder (SAD), even in the absence of a formal autism diagnosis. Furthermore, the concept of the broader autism phenotype (BAP) suggests that subclinical autism-related features may be observed in parents of individuals with autism traits.

This study includes 109 adolescents (aged 11-17) diagnosed with SAD and their parents. The adolescents completed a standardized scale assessing social anxiety severity, while parents completed the Social Responsiveness Scale (SRS) for their children and the Autism Spectrum Quotient (AQ) to assess BAP characteristics in themselves. The study aimed to explore the associations between adolescents' autism-related traits and their social anxiety severity, and to evaluate how parental BAP scores (particularly fathers') may be associated with these traits.

Note: This study involved prospective recruitment and data collection; however, registration was completed retrospectively after the study was completed.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adolescents aged 11-17 years diagnosed with Social Anxiety Disorder (SAB). Availability of at least one biological parent willing to participate. Ability to provide informed consent/assent.

Exclusion criteria

Presence of intellectual disability or severe neurological disorder. Comorbid psychiatric diagnoses that could interfere with assessment (e.g., psychosis).

Non-fluency in the language of assessment.

Treatment and study plan

No intervention (observational study)

Other

This is an observational study with no intervention applied.

Primary outcomes

  1. Social Anxiety Severity

    Time frame: At baseline

    Severity of social anxiety symptoms measured by the Social Anxiety Disorder Severity Scale - Child Form.

Secondary outcomes

  1. Autism Traits in Adolescents

    Time frame: At baseline

    Autism spectrum traits in adolescents assessed by the Social Responsiveness Scale, completed by parents.

Other outcomes

  1. Parental Broader Autism Phenotype

    Time frame: At baseline

    Parental broader autism phenotype evaluated using the Autism Spectrum Questionnaire.

Sponsors and collaborators

Lead sponsor

Ankara City Hospital Bilkent

Other

Registry information

Official study title

Identification of Autism Traits in Adolescents With Social Anxiety Disorder and Evaluation of Their Association With the Broader Autism Phenotype in Their Parents

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Aug 6, 2025
Registry last updated
Aug 6, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.